153 related articles for article (PubMed ID: 29746612)
1. Clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of Cases.
Kuang M; Shen X; Yuan C; Hu H; Zhang Y; Pan Y; Cheng C; Zheng D; Cheng L; Zhao Y; Tao X; Li Y; Chen H; Sun Y
Am J Clin Pathol; 2018 May; 150(1):65-73. PubMed ID: 29746612
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.
Bossé Y; Gagné A; Althakfi W; Orain M; Fiset PO; Desmeules P; Joubert P
Hum Pathol; 2022 Oct; 128():56-68. PubMed ID: 35872155
[TBL] [Abstract][Full Text] [Related]
3. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
Fan J; Dai X; Wang Z; Huang B; Shi H; Luo D; Zhang J; Cai W; Nie X; Hirsch FR
Clin Lung Cancer; 2019 Jul; 20(4):e517-e530. PubMed ID: 31138506
[TBL] [Abstract][Full Text] [Related]
4. The prognostic implications of EGFR mutation and ALK rearrangement for the long-term outcomes of patients with resected lung adenocarcinomas.
Kim H; Lee HJ; Hong H; Kim YJ; Kim KG; Jeon YK; Kim YT
Thorac Cancer; 2019 Jul; 10(7):1619-1627. PubMed ID: 31215177
[TBL] [Abstract][Full Text] [Related]
5. Resected stage I anaplastic lymphoma kinase-positive lung adenocarcinoma has a negative impact on recurrence-free survival.
Fujibayashi Y; Tane S; Kitazume M; Kuroda S; Kimura K; Kitamura Y; Nishio W
Thorac Cancer; 2022 Apr; 13(8):1109-1116. PubMed ID: 35274461
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma.
Zhang H; Shan G; Cai B; Bi G; Chen Z; Liang J; Besskaya V; Zheng Y; Guo W; Wang L; Xu S; Zhan C
Thorac Cancer; 2021 Nov; 12(22):3011-3018. PubMed ID: 34596344
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological features of lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangements].
Dong Y; Zhou L; Wang J; Cai Y; Mu J; Zhang H
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):436-40. PubMed ID: 26463147
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact and distinctive characteristics of surgically resected anaplastic lymphoma kinase-rearranged lung adenocarcinoma.
Matsuura Y; Ninomiya H; Ichinose J; Nakao M; Okumura S; Nishio M; Mun M
J Thorac Cardiovasc Surg; 2022 Feb; 163(2):441-451.e1. PubMed ID: 33131892
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.
Li X; Zhao C; Su C; Ren S; Chen X; Zhou C
BMC Cancer; 2016 Oct; 16(1):828. PubMed ID: 27793199
[TBL] [Abstract][Full Text] [Related]
10. [To evaluate the clinicopathologic characteristics and outcome of tumor cells spreading through air spaces in patients with adenocarcinoma of lung].
Sun PL; Liu JN; Cao LQ; Yao M; Gao HW
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):303-308. PubMed ID: 28468034
[No Abstract] [Full Text] [Related]
11. Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populations.
Zheng D; Wang R; Zhang Y; Pan Y; Cheng X; Cheng C; Zheng S; Li H; Gong R; Li Y; Shen X; Sun Y; Chen H
J Cancer Res Clin Oncol; 2016 Apr; 142(4):833-43. PubMed ID: 26646246
[TBL] [Abstract][Full Text] [Related]
12. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma.
Deng C; Zhang Y; Ma Z; Fu F; Deng L; Li Y; Chen H
J Thorac Cardiovasc Surg; 2021 Sep; 162(3):664-674.e7. PubMed ID: 32747123
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the cribriform pattern in invasive adenocarcinoma of the lung.
Zhang R; Hu G; Qiu J; Wu H; Fu W; Feng Y; Zhang M; Chen C; Sun J; Zhang Y; Ren J
J Clin Pathol; 2019 Oct; 72(10):682-688. PubMed ID: 31253654
[TBL] [Abstract][Full Text] [Related]
15. Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib.
Yang CY; Liao WY; Ho CC; Chen KY; Tsai TH; Hsu CL; Liu YN; Su KY; Chang YL; Wu CT; Liao BC; Hsu CC; Hsu WH; Lee JH; Lin CC; Shih JY; Yang JC; Yu CJ
Oncologist; 2020 Aug; 25(8):702-711. PubMed ID: 32386255
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs Analysis.
Frost N; Zhamurashvili T; von Laffert M; Klauschen F; Ruwwe-Glösenkamp C; Raspe M; Brunn M; Ochsenreither S; Temmesfeld-Wollbrück B; Suttorp N; Grohé C; Witzenrath M
Clin Lung Cancer; 2020 Nov; 21(6):e607-e621. PubMed ID: 32620471
[TBL] [Abstract][Full Text] [Related]
17. Cribriform Subtype is an Independent Predictor of Recurrence and Survival After Adjustment for the Eighth Edition of TNM Staging System in Patients With Resected Lung Adenocarcinoma.
Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
J Thorac Oncol; 2019 Feb; 14(2):245-254. PubMed ID: 30336325
[TBL] [Abstract][Full Text] [Related]
18. Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status.
Arrieta O; Ramírez-Tirado LA; Caballé-Perez E; Mejia-Perez A; Zatarain-Barrón ZL; Cardona AF; Lozano-Ruíz F; Segura-González M; Cruz-Rico G; Maldonado F; Rosell R
Thorac Cancer; 2020 Apr; 11(4):1026-1037. PubMed ID: 32072746
[TBL] [Abstract][Full Text] [Related]
19. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features.
Pan Y; Zhang Y; Li Y; Hu H; Wang L; Li H; Wang R; Ye T; Luo X; Zhang Y; Li B; Cai D; Shen L; Sun Y; Chen H
Lung Cancer; 2014 May; 84(2):121-6. PubMed ID: 24629636
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features of 54 cases of lung adenocarcinomas with c-ROS oncogene 1 fusion].
Cao H; Zheng J; Zhao J; Guo XJ; Zhou JY; Ding W; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):120-125. PubMed ID: 32062881
[No Abstract] [Full Text] [Related]
[Next] [New Search]
